Press Release

Rise in Patient Pool of Orthopedic Trauma to Drive the Bone Grafts & Substitutes Market Globally

According to MarkNtel Advisors, the Global Bone Grafts & Substitutes Market is expecting around 5.6% CAGR during 2022-27. The mounting instances of bone & joint disorders leading to massive investments in developing new bone grafts & substitutes with enhanced biocompatibility, the rapidly rising geriatric population, increasing public interest in minimally invasive surgeries, and the growing awareness among patients about the significance & benefits of bone reconstruction, are the prime aspects driving the global market.

Moreover, surging cases of periodontal & orthopedic diseases, widespread availability of advanced bone grafts & substitutes in different shapes & sizes, and various ongoing R&D activities worldwide toward improving the bioactivity of bone grafts & substitutes are other crucial aspects projected to drive the global market through 2027, further states the research report, "Global Bone Grafts & Substitutes Market Analysis, 2022."

Excellent Biocompatibility of Synthetic Bone Substitutes to Boost the Global Market through 2027

Synthetic bone substitutes are mainly of two types; Polymer & Ceramic. They possess superior biocompatibility and fewer chances of disease transmission, i.e., why they are the most accepted materials among patients worldwide and hold the majority share in the Global Bone Grafts & Substitutes Market.

Of both synthetic materials, ceramics help retain the bone position and minimize the risks of infections. Moreover, their benefits like short surgery time, finite blood loss, & lower pain, among others, make them the preferred choice among patients worldwide.

With Class-Leading Healthcare Facilities in the US, North America Dominates the Market

North America has one of the world's finest healthcare infrastructures, with massive expenditure by both governments & private sectors across many countries. The region is the early adopter of advanced technologies and is currently witnessing a rapid surge in orthopedic surgeries & a mounting inclination of people toward minimally invasive surgeries.

In North America, the US is observing the maximum need for bone grafts & substitutes. It attributes to the increasing prevalence of orthopedic trauma and rapid technological advance across the healthcare sector in the country. Moreover, the rising awareness about the various advantages of synthetic bone substitutes and the extensively available industry leaders coming up with innovative & efficient products are other crucial aspects propelling the regional market growth, reveals MarkNtel Advisors in their research report, "Global Bone Grafts & Substitutes Market Analysis, 2022."

Competitive Landscape

The leading players in the Global Bone Grafts & Substitutes Market include AlloSource, Baxter, Biobank, DePuy Synthes, Inc., Geistlich Pharma AG, Medtronic, NuVasive, Inc., OST Développement, Smith & Nephew, Inc., Stryker Corporation, TBF Tissue Engineering, Wright Medical Group N.V., and Zimmer Biomet.

Key Questions Answered in the Research Report:

1. What are the current & future trends in the Global Bone Grafts & Substitutes Market?
2. How has the industry been evolving in terms of geography & product adoption?
3. How has the competition been shaping across various countries, followed by their comparative factorial indexing?
4. What are the key growth drivers & challenges for the Global Bone Grafts & Substitutes Market?
5. What are the customer orientation, purchase behavior, & expectations from the manufacturers of bone grafts & substitutes across various regions?

Market Segmentation:

1. By Material Type (Allograft (Demineralized Bone Matrix (DBM)), Autograft, Synthetic (Polymer, Ceramic (Hydroxyapatite (HA), ß-TCP)), Xenograft)
2. By Application (Craniomaxillofacial, Spinal Fusion, Foot & Ankle, Dental, Joint Reconstruction)
3. By End-Users (Hospitals, Specialty Clinics)
4. By Region (North America, South America, Europe, Middle East & Africa, Asia-Pacific)
5. By Countries (The US, Canada, Mexico, Brazil, Italy, France, The UK, Germany, Spain, South Africa, China, India, Japan, Australia, South Korea)
6. By Companies (AlloSource, Baxter, Biobank, DePuy Synthes, Inc., Geistlich Pharma AG, Medtronic, NuVasive, Inc., OST Développement, Smith & Nephew, Inc., Stryker Corporation, TBF Tissue Engineering, Wright Medical Group N.V., Zimmer Biomet)